Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma

Cancer Prevention Research

Volumn 1, Issue 5, 2008, Pages 308-311

  Blaser, Martin J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BIODIVERSITY; DEVELOPED COUNTRY; DISEASE PREDISPOSITION; ESOPHAGUS TUMOR; EVOLUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; NOTE; PHYSIOLOGY; STATISTICS;

ADENOCARCINOMA; BIODIVERSITY; DEVELOPED COUNTRIES; DISEASE SUSCEPTIBILITY; ESOPHAGEAL NEOPLASMS; EVOLUTION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 61549127941     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0170     Document Type: Review

References (50)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83: 2049-53.
2. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002;102:422-7.
3. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-56.
4. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
5. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Heliobacter pylori seropositivity. J Natl Cancer Inst 2006;98: 1445-52.
6. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
7. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 2007;109:668-74.
8. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008;57:734-9.
9. Winkelstein A. Peptic esophagitis: a new clinical entity. JAMA 1935;104:906-8.
10. Jansson C, Johansson AL, Nyren O, Lagergren J. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14:1754-61.
11. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
12. Corley DA, Kubo A, Levin TR, et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008;57: 727-33.
13. Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007;445: 915-8.
14. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
15. Blaser MJ, Atherton J. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004;113: 321-33.
16. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 2006;103:732-7.
17. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004;4:688-94.
18. Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004;5:1166-74.
19. Pillinger MH, Marjanovic N, Kim S-Y, et al. Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and independent ERK activation. J Biol Chem 2007;282:18722-31.
20. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
21. Perez-Perez GI, Salomaa A, Kosunen TU, et al. Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut 2002;50:295-8.
22. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008;198:553-60.
23. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
24. Fukase K, Kato M, Kikuchi S, et al for the Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-97.
25. Fock KM, Talley NJ, Moayyedi P, et al. Asia Pacific Consensus Guideline on gastric cancer prevention. J Gastroenterol Hepatol 2008;23: 351-65.
26. Basso D, Zambon CF, Letley DP, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008;135: 91-9.
27. Plummer M, van Doorn LJ, Franceschi S, et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 2007;99:1328-34.
28. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res 2008;1:329-38.
29. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007; 5:1413-17.
30. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
31. Oksanen A, Sipponen P, Karttunen R, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000; 46:460-3.
32. Francois F, Roper J, Groodman A, et al. The association of gastric leptin with oesophageal inflammation and metaplasia. Gut 2008;57:16-24.
33. de Martel C, Haggerty TD, Corley DA, Vogelman JH, Orentreich N, Parsonnet J. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 2007;102:1166-72.
34. Lundgren A, Strömberg E, Sjöling A, et al. Mucosal FOXP3-expressing CD4+ CD25 high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 2005;73:523-31.
35. Robinson K, Kenefeck R, Pidgeon E, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T-cell responses. Gut 2008.
36. Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A 2004;101:4250-5.
37. Blaser MJ. Understanding microbe-induced cancers. Cancer Prev Res 2008;1:15-20.
38. Ogilvie AL, James PD, Atkinson M. Impairment of vagal function in reflux oesophagitis. Q J Med 1985;54:61-74.
39. Haenszel W. Variation in incidence of and mortality from stomach cancer, with particular reference to the United States. J Natl Cancer Inst 1958;21: 213-62.
40. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 2006;7:956-60.
41. Hurrell RF. Preventing iron deficiency through food fortification. Nutr Rev 1997;55:210-22.
42. Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001;22:1119-29.
43. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995;4:85-92.
44. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2007;57:173-80.
45. Ghose C, Perez-Perez GI, van Doorn LJ, Dominguez-Bello MG, Blaser MJ. High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects. J Clin Microbiol 2005;43:2635-41.
46. Blaser MJ, Kirschner D. The equilibria that permit bacterial persistence in human hosts. Nature 2007; 449:843-9.
47. Andersson AF, Lindberg M, Jakobsson H, Bäckhed F, Nyrén P, Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing.PLoSONE 2008;3:e2836.
48. Pei Z, Yang L, Peek RM, Levine SM, Pride DT, Blaser MJ. Bacterial biota in reflux esophagitis and Barrett's esophagus. World J Gastroenterol 2005;11:7277-83.
49. Blaser MJ. The changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179:1523-30.
50. Hill AB. The environment and disease: association or causation? Proc Soc Med 1965;58: 295-300.